About 5,000 lawsuits are pending, including some from patients crippled by tiny particles of metallic debris
The DePuy orthopedic division of Johnson & Johnson, citing declining sales, began phasing out both models of the device — formally known as an articular surface replacement device, which DePuy marketed under the name ASR — in November 2009 and formally recalled them in August 2010 amid reports in databases of orthopedic patients abroad showing they were failing prematurely at high rates.
Health Glance
Bexarotene has been approved for the treatment of cancer by the U.S. Food and Drug Administration for more than a decade. These experiments explored whether the medication might also be used to help patients with Alzheimer's disease, and the results were more than promising.
Texas attorney general has filed charges against Big Pharma for bribing officials to implement an elaborate scheme to fraudulently diagnose and medicate teenagers for mental illness.
Seeking to allay the concerns of Catholic leaders and head off an escalating political storm, President Obama on Friday announced an adjustment to the administration’s health-care rule requiring religiously affiliated employers to provide contraceptive coverage to women.
One of the two active ingredients that made up Agent Orange is 2,4-D. Despite what Agent Orange did to Vietnam and the Vietnamese people, not to mention a generation of American soldiers, 2,4-D is currently the most widely used herbicide in the world, and the third most commonly used in North America. But apparently we aren’t using this poison enough. By using seeds engineered to withstand it, much more can be applied to our soil and crops.
Cardiac computed tomography (CT) and other medical scans sometimes involve injecting a radioactive iodide dye into the bloodstreams of patients in order to highlight the produced images. But a new study published in the journal Archives of Internal Medicine has revealed that this radioactive dye can cause permanent thyroid damage, as well as cancer.
A safe and effective cure for cancer has been discovered with a drug that was once used for unusual metabolic problems. Yet, the cancer industry shows no interest with following up on dichloroacetate (DCA) research from University of Alberta in Edmonton, Canada, reported in 2007. That's because DCA is no longer patented.





























